OTC Markets OTCQB - Delayed Quote USD

Zeo ScientifiX, Inc. (ZEOX)

2.0500
+0.0700
+(3.54%)
At close: June 13 at 1:44:30 PM EDT
Loading Chart for ZEOX
  • Previous Close 1.9800
  • Open 2.0500
  • Bid 2.0000 x 444600
  • Ask 2.0500 x 50000
  • Day's Range 2.0500 - 2.0500
  • 52 Week Range 1.2500 - 4.7300
  • Volume 1,259
  • Avg. Volume 4,834
  • Market Cap (intraday) 13.222M
  • Beta (5Y Monthly) 5.42
  • PE Ratio (TTM) --
  • EPS (TTM) -0.8000
  • Earnings Date Jun 12, 2025 - Jun 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. The company's lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. It also provides Patient Pure X, an autologous blood-derived biologic technology, that helps the body's natural ability to decrease cellular inflammation and promote tissue healing. In addition, the company develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROW X, a professional-grade formula that delivers a concentrated dose of topical exosomes that help support follicular function; ZEO GROW BOOST; and EXO FOLLICLE FUEL. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is headquartered in Davie, Florida.

www.zeoscientifix.com

20

Full Time Employees

October 31

Fiscal Year Ends

Recent News: ZEOX

View More

Performance Overview: ZEOX

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZEOX
34.08%
S&P 500 (^GSPC)
1.62%

1-Year Return

ZEOX
13.89%
S&P 500 (^GSPC)
10.00%

3-Year Return

ZEOX
39.71%
S&P 500 (^GSPC)
59.40%

5-Year Return

ZEOX
84.23%
S&P 500 (^GSPC)
96.53%

Compare To: ZEOX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZEOX

View More

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    13.22M

  • Enterprise Value

    13.20M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.87

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.90

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -107.73%

  • Return on Assets (ttm)

    -169.83%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.56M

  • Net Income Avi to Common (ttm)

    -4.91M

  • Diluted EPS (ttm)

    -0.8000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    720k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    589.38k

Research Analysis: ZEOX

View More

Company Insights: ZEOX

Research Reports: ZEOX

View More

People Also Watch